NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

UTI Asset Management Company Experiences Weak Quarter, Adjusts Outlook

The research report by Prabhudas Lilladher on UTI Asset Management Company has highlighted a weak quarter for the company, with core Profit After Tax (PAT) missing projected levels by 11.5%. This underperformance is attributed to two primary factors: a lower revenue base due to a shift in mix towards exchange-traded funds (ETFs), and higher operational expenses (opex) driven by other opex.

The management has provided guidance on post-VRS (Voluntary Retirement Scheme) staff costs, indicating that quarterly staff expenses could range between INR 1.25 billion and INR 1.30 billion. Additionally, other opex is expected to grow by 10% primarily due to increased technology spending and geographic expansion. In response to the 5 basis points (bps) increase in Total Expense Ratio (TER), UTI Asset Management plans to pass on this impact to intermediaries.

Adjusted Estimates

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

In light of these developments, Prabhudas Lilladher has increased the company's operational expenses for FY27/28E by 5.3% and 7.9%, respectively. Consequently, core PAT has been reduced by an average of 10.5%. These revisions have a bearing on the company's earnings per share (EPS) and, subsequently, its target price.

Outlook and Recommendations

Despite maintaining a multiple of 13x on Mar'28 core EPS, Prabhudas Lilladher has adjusted its target price to INR 975 from INR 1,125. This change in target price is a direct result of the earnings cut. The research firm has also shifted its rating to 'HOLD' from 'BUY'.

MetricOriginal EstimateRevised Estimate
Opex Growth (FY27/28E)-5.3% / 7.9%
Staff Cost (INR bn)-1.25-1.30
Core PAT Reduction (Avg.)-10.5%
Target Price (INR)1,125975
RatingBUYHOLD

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Investor Takeaway

Investors should be cautious with UTI Asset Management Company due to a weak quarter and earnings cut.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.